Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLCAlexa B. Turke, Pasi A. Jänne, Dora Dias‐Santagata et al.|Cancer Cell|2010Cited by 1.1k
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody CetuximabKimio Yonesaka, Pasi A. Jänne, Kreshnik Zejnullahu et al.|Science Translational Medicine|2011Cited by 670